Cargando…
SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
PURPOSE OF REVIEW: SGLT2 inhibitors (SGLT2i) are new drugs for patients with heart failure (HF) irrespective of diabetes. However, the mechanisms of SGLT2i in HF remain elusive. This article discusses the current clinical evidence for using SGLT2i in different types of heart failure and provides an...
Autores principales: | Pabel, Steffen, Hamdani, Nazha, Luedde, Mark, Sossalla, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484236/ https://www.ncbi.nlm.nih.gov/pubmed/34523061 http://dx.doi.org/10.1007/s11897-021-00529-8 |
Ejemplares similares
-
Single-Cell RNA Sequencing of the Adult Mammalian Heart—State-of-the-Art and Future Perspectives
por: Gladka, Monika M.
Publicado: (2021) -
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management
por: Cuomo, Alessandra, et al.
Publicado: (2021) -
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021) -
Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2021) -
Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)